Toggle navigation
Search
Tree View
MeSH on Demand
MeSH 2025
About
Suggestions
Contact Us
lorvotuzumab mertansine
MeSH Supplementary Concept Data 2024
Details
Concepts
MeSH Supplementary
lorvotuzumab mertansine
Unique ID
C579429
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C579429
Entry Term(s)
BB-10901
IMGN-901
IMGN901
Pharm Action
Immunotoxins
Antineoplastic Agents, Phytogenic
Antineoplastic Agents, Immunological
Registry Numbers
0IVD6ASY0W
Heading Mapped to
*Antibodies, Monoclonal
Maytansine
/
analogs & derivatives
Frequency
11
Note
has antineoplastic activity; structure in first source
Source
AAPS J. 2012 Dec;14(4):799-805.
Date of Entry
2013/04/02
Revision Date
2019/10/31
Expand All
Collapse All
lorvotuzumab mertansine
Preferred
Concept UI
M0582676
Registry Numbers
0IVD6ASY0W
Terms
lorvotuzumab mertansine
Preferred Term
Term UI
T839691
Date
04/02/2013
LexicalTag
NON
ThesaurusID
IMGN901
Narrower
Concept UI
M0582677
Terms
IMGN901
Preferred Term
Term UI
T839692
Date
04/02/2013
LexicalTag
LAB
ThesaurusID
NLM (2013)
IMGN-901
Term UI
T000967336
Date
09/05/2019
LexicalTag
LAB
ThesaurusID
NLM (2020)
BB-10901
Narrower
Concept UI
M000655060
Terms
BB-10901
Preferred Term
Term UI
T000967340
Date
09/05/2019
LexicalTag
LAB
ThesaurusID
NLM (2020)
page delivered in 0.005s